US FDA Approved Roche’s Cobas SARS-CoV-2 Duo for Emergency Use
Roche Announced that, the Food and Drug Administration (FDA) of the United States has issued emergency use authorization (EUA) for the cobas SARS-CoV-2 Duo for use on the fully automated cobas 6800/8800 Systems, along with expanding the covid-19 portfolio of Roche. This has been first automated and real-time RT-PCR assay for the in vitro qualitative […]
Continue Reading